Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Immunoassay Instruments Market OutlookCompetitive Scenario of the Market, Major Competitors, Share and Future Prospects

Immunoassay is a laboratory based diagnostic procedure that is performed using an immunological reaction of antibodies.
Rahul Gautam | 26.04.2018
Immunoassay Instruments © Rahul Gautam
The immunoassay instruments market is growing with a considerable rate due to rising incidence of chronic infectious diseases, increasing preference for personalized medicine, and technological advancements. Investments in emerging economies, and focus on developing compact, reliable and portable immunoassay instruments are some of the factors giving ample opportunities to the immunoassay instruments market to grow in the coming years.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market

On the basis of technology, the immunoassay instruments market can be categorized as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay, rapid tests, polymerase chain reaction, western blot, and ELISPOT. Enzyme-linked immunosorbent assay includes 1st generation ELISA tests, 2nd generation ELISA tests, 3rd generation ELISA tests and 4th generation ELISA tests.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market/report-sample

North America dominates the immunoassay instruments market due to expanding biotechnology and pharmaceutical industries, rising incidences of chronic diseases, government support and the launch of new products in the region. Asia-Pacific is expected to grow at the highest rate in the coming years.

Some of the competitors in the immunoassay instruments market are Beckman Coulter, Inc., F. Hoffman-La Roche, Ltd., Thermo Fisher Scientific, Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation.